HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brain angiotensin receptors and sympathoadrenal regulation during insulin-induced hypoglycemia.

Abstract
Simultaneous blockade of systemic AT1 and AT2 receptors or converting enzyme inhibition (CEI) attenuates the hypoglycemia-induced reflex increase of epinephrine (Epi). To examine the role of brain AT1 and AT2 receptors in the reflex regulation of Epi release, we measured catecholamines, hemodynamics, and renin during insulin-induced hypoglycemia in conscious rats pretreated intracerebroventricularly with losartan, PD-123319, losartan and PD-123319, or vehicle. Epi and norepinephrine (NE) increased 60-and 3-fold, respectively. However, the gain of the reflex increase in plasma Epi (Deltaplasma Epi/Deltaplasma glucose) and the overall Epi and NE responses were similar in all groups. The ensuing blood pressure response was similar between groups, but the corresponding bradycardia was augmented after PD-123319 (P < 0.05 vs. vehicle) or combined losartan and PD-123319 (P < 0.01 vs. vehicle). The findings indicate 1) brain angiotensin receptors are not essential for the reflex regulation of Epi release during hypoglycemia and 2) the gain of baroreceptor-mediated bradycardia is increased by blockade of brain AT2 receptors in this model.
AuthorsR H Worck, D Staahltoft, T E Jonassen, E Frandsen, H Ibsen, J S Petersen
JournalAmerican journal of physiology. Regulatory, integrative and comparative physiology (Am J Physiol Regul Integr Comp Physiol) Vol. 280 Issue 4 Pg. R1162-8 (Apr 2001) ISSN: 0363-6119 [Print] United States
PMID11247840 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Blood Glucose
  • Imidazoles
  • Insulin
  • Pyridines
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Receptors, Angiotensin
  • Angiotensin II
  • PD 123319
  • Losartan
  • Norepinephrine
  • Epinephrine
Topics
  • Angiotensin II (administration & dosage, pharmacology)
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors (pharmacology)
  • Animals
  • Blood Glucose (drug effects, metabolism)
  • Blood Pressure
  • Brain (drug effects, physiology)
  • Cerebral Ventricles (drug effects, physiology)
  • Epinephrine (blood)
  • Heart Rate
  • Hemodynamics (drug effects, physiology)
  • Homeostasis
  • Hypoglycemia (chemically induced, physiopathology)
  • Imidazoles (administration & dosage, pharmacology)
  • Injections, Intraventricular
  • Insulin (pharmacology)
  • Losartan (administration & dosage, pharmacology)
  • Male
  • Norepinephrine (blood)
  • Pyridines (administration & dosage, pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Receptors, Angiotensin (physiology)
  • Reflex (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: